Coherus Biosciences
Develops and commercializes high-quality biosimilar therapeutics worldwide using advanced analytics.
Develops and commercializes high-quality biosimilar therapeutics worldwide using advanced analytics.
Sector
Life SciencesCategory
TherapeuticsLocation
Redwood City, CAInitial Investment
2014Coherus Biosciences (NASDAQ: CHRS) is a biosimilar-focused, biologics platform company with the cutting-edge analytics, process science, and clinical and regulatory capabilities to develop and commercialize high-quality biosimilar therapeutics worldwide.